Msi2 has been reported to be overexpressed in human lung adenocarcinoma and regional metastases, and its inhibition in human cell lines has been shown to reduce invasive and metastatic potential in vitro (Kudinov et al., 2016; Moreira et al., 2010). Here, MSI2 is linked to lung adenocarcinoma.